Business
Raamdeo Agarwal: We may see rapid growth over the next few years: Raamdeo Agrawal
The central government has complete power with a clear mandate, but directives from the Centre have to be executed well at the state level. So, there are many things that are still not in Modi’s hands, says Raamdeo Agrawal, Joint Managing Director, Motilal Oswal Financial Services in an interview with Narendra Nathan and Sanket Dhanorkar.
Are we looking at a multi-year bull run?
I think the market has not yet priced in the full potential of the economy. For the first time, a true nationalist has come to power with a clear majority. There is a new-found energy across the nation. My sense is that the market has not yet understood the difference between 300-plus seats for NDA and 272-plus seats for BJP alone. Look at how the cabinet posts have been assigned — BJP allies have got limited posts and their negotiating power is diminished. Complete power is in the hands of the government. The political scenario is drastically different now. The economy is on the cusp of a historical positive change.
It is the same vehicle, but the driver has changed. It is now being steered by a formula-one driver. So, the acceleration will be dramatic. It will become visible very quickly. Today we are growing at 4.5 per cent. Growth is likely to pick up pace rapidly in the next few years. A lot of things will happen in five years. It will be interesting to see the index level at that time. In the process, investors will make tons of money, because the market will discount that growth two years in advance. It will not wait for the fifth year. If all domestic and global factors align, markets will go through the roof.
Are there challenges to the fragile economic recovery?
The current optimism is because a major variable — the shambolic political setup — has been corrected. There is no doubt that the new government has been fully empowered in this election; the mandate has been given to an extremely competent individual. Right now, everybody is bullish. But one must have tempered expectations. Finally, directives from the Centre have to be executed well at the state level. Otherwise it will be a waste. There are many things that are still not in Modi’s hands.
A lot of other factors will also play a role. Good monsoons, favourable global environment, peaceful borders, etc., can change the entire scenario. But, only time will tell how many stars will align. So, a lot will depend on external factors. I am also keenly watching how the new government tackles inflation, which is just a symptom of a much deeper problem somewhere else. The government has to address supply-side bottlenecks. A weak currency cannot make a strong country. That is why, inflation must go down. It will be the beginning of development, investments, and so on.
The rally, so far, has been driven by hope. When will fundamentals take over?
News headlines, and making money are two entirely different things. We should not get carried away by the headlines. The focus must be on who will actually make money. In most cases, it will be a company which is making money right now. Very rarely will a company that is broke today make money tomorrow, unless there is a complete change in business dynamics. Today, we do not have anything to go by. So, wherever there are anomalies in the economy, these will come back to normal levels. Right now, it is only about the promise of a better tomorrow. Some of these promises will have to take shape in the budget.
undefined
What should be the first priority for the new government?
India has to become much more business friendly. Finally, the country needs to create jobs for its rising young population. Who will create these jobs? More than the government, it is the businesses which will create jobs. Businesses can create jobs only if the business environment is friendly. They also cannot sustain growth without creating jobs. So, the government has to become business friendly. All hurdles should be removed. We need businesses to take more risks as it will result in more jobs.
Will mid-cap stocks continue to perform better than large-caps for now?
It really depends on the company. Mid-caps were lagging for quite some time; smallcaps even more. Eventually it has to converge. Large-caps are now looking highly priced. Investor appetite is limited at these levels. Most of the action is in the low-quality, low-priced segment. Smaller investors are clearly buying low-quality stuff, thinking that the price is low. But, even if it moves into high valuation territory, low quality will remain so. This is where the entire game ends. Sure, high quality stocks are expensive now. But that doesn’t mean you should have junk in your portfolio. If you find quality at a reasonable price, buy with modest expectations. Such names are few and far between. But, even if you get 3-4 such ideas over one year, you can make money. The challenge is to have patience and hold on to the investment. Filling with junk will be a disaster, but if it works, you get a multi-bagger. Investors in high quality may underperform in a rallying market, but will emerge better off over an entire cycle.
Can we expect an earnings upgrade anytime soon?
A 12-15 per cent earnings upgrade is definitely possible this year. As the economy recovers, sectors, such as cement, steel and automobiles, will pick up pace. Oil & gas can also contribute to earnings growth. Right now corporate profits are contributing around 4 per cent to the GDP, which is near the bottom of the band. At the peak of a cycle, this can go upto 7-8 per cent. Assuming 13-14 per cent nominal growth in GDP, it will double in rupee term to Rs 220 trillion in next six years. Now the question is whether the current profit of Rs 4 trillion will move up to Rs 8 trillion or Rs 16 trillion. If it maintains the current ratio, it will go to Rs 8 trillion. If it touches the upper end of the band, it will go to Rs 16 trillion. If this happens and the PE multiple remains the same, the market will go up four times. Profits will zoom the moment the economy moves from 5-6 per cent to 8-9 per cent growth. That is why there is a potential for the market to go up to the stratospheric levels from here.
Business
At Close of Business podcast March 31 2026
Isabel Vieira and Mark Pownall discuss a restructure with WA’s biggest wine maker Fogarty Wine Group.
Business
Apartments planned above resort’s iconic former Woolworths store

Amendments made to project at Art Deco landmark
Business
Perth family law firm Paterson & Dowding wins injunction to protect stolen data
A boutique Perth family law firm has been granted an injunction over data stolen during a recent cyber attack, preventing it from being accessed and shared by Australian outlets or companies.
Business
US petrol price tops $4 for first time since 2022
The Iran war continues to push up prices at the pump for US motorists.
Business
Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs
Wegovy semaglutide tablets.
Michael Siluk | Universal Images Group | Getty Images
Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, “predictable” monthly prices.
Eligible patients can choose between three-, six- or 12-month subscriptions for the Wegovy injection or the two highest doses of the newly launched pill under the same brand name. Longer plans offer lower monthly pricing, and the company expects people to save up to $1,200 a year on the injection and as much as $600 a year on the pill, relative to paying for their individual dose each month, according to a Novo release.
Patients can expect to pay flat monthly prices, even if they move to different doses, the company said. The subscription program will be available starting Tuesday on several of Novo’s telehealth partners, including Ro, WeightWatchers, LifeMD, Sesame and Hims & Hers, with more expected to be added soon.
The first-of-its-kind offering is “an opportunity to help patients not only start but stay on therapy and help them manage the ups and downs of some of the pricing considerations,” regardless if they are starting treatment or are currently taking the drug, said Ed Cinca, Novo’s head of marketing and patient solutions.
Inability to stay on GLP-1s is a longstanding issue due to factors such as difficulty accessing the drugs and gastrointestinal side effects, with one 2025 study estimating that around 65% of patients with obesity stop treatment within a year.
Wegovy subscription prices and estimated savings
Injection subscription plans (0.25, 0.5, 1.7 and 2.4 milligram doses)
- 3-month: $329 per month, savings of $240 per year
- 6-month: $299 per month, savings of $600 per year
- 12-month: $249 per month, savings of $1,200 per year
Pill subscription plans (9 and 25 milligram doses)
- 3-month: $289 per month, savings of $120 per year
- 6-month: $269 per month, savings of $360 per year
- 12-month: $249 per month, savings of $600 per year
The new program also comes as Novo’s pill, which has seen explosive uptake since its U.S. launch in January, is set to face fresh competition from an upcoming oral GLP-1 from chief rival Eli Lilly later this year. Lilly is currently the dominant player in the branded GLP-1 market in the U.S., with an estimated 60% share, while Novo has about 39%.
The Wegovy pill has largely been reaching people who didn’t previously take GLP-1 injections, making it crucial for Novo to capture as many new patients as it can before a competitor arrives.
As Novo Nordisk’s subscription plans launch, cash-paying patients can still pay $149 per month for the lower doses of the pill, which are 1.5 and 4 milligrams. But starting in August, the 4-milligram dose will cost $199 per month. Meanwhile, the recently approved 7.2-milligram dose of Wegovy will be added to the subscription program at a later date.
Cinca emphasized that patients can opt out of the subscription while it’s active if they no longer wish to enroll.
“We want to help patients identify a path that can help them feel comfortable about treating [obesity] in the long term,” he added.
Cinca said Novo is not yet offering the program on its NovoCare direct-to-consumer pharmacy, but added that there’s “an opportunity to evaluate how this goes and then build it out” through that platform over time.
Business
Bulls to return after March massacre? Elara sees limited downside for Nifty after 11% crash amid Iran-US war
The domestic brokerage cited data from the timeframes of seven major geopolitical conflicts in the past 25 years – Iraq war (2003), the Lebanon war (2006), the Libyan Civil War (2011), Russia–Ukraine (2022), Israel–Hamas war (2023), Iran–Israel conflict (2025), and the ongoing US–Iran escalation. It said that Nifty’s drawdown during the onset of conflicts has usually been capped at approximately 10%. Hence, historical patterns suggest limited downside for the benchmark index now, after the 11% crash in March.
“Importantly, once early signs of normalisation emerge, markets tend to recover swiftly,” Elara said. However, it noted that the key exception to this historical pattern was in calendar years 2011-2014 when Brent sustained above $100 per barrel, leading to a prolonged sideways market without meaningful highs. The eventual decline in oil prices acted as the trigger for a strong Nifty upcycle, it added.
Also read: Sammaan Capital becomes IHC Group co, receives Rs 5,652 cr in first tranche of stake sale
Nifty’s valuation below the long-term trend signals a potential rebound
Elara assessed the one-year forward P/E relative to its rolling 10-year average and concluded the Nifty is trading 7% below its 10-year average, placing it in a historical “bounce zone”. “Outside of extreme disruptions like COVID-19, this level usually acted as a floor for valuation. Even during the Russia–Ukraine conflict, despite Brent sustaining above USD 100/bbl, Nifty multiples bounced back from 10-year rolling averages,” it said.
“The recent TACO and Iran allowing ‘nonhostile ships’ to transit the Strait of Hormuz, along with crude oil prices dropping below USD 100/bbl, have reduced immediate energy supply risks. With our base case assuming gradual de-escalation, the current valuation provides a favourable entry point, with limited downside. We pick 20 value plays which offer a good risk-reward opportunity with healthy fundamentals in the current scenario of extreme correction,” the brokerage added.
Elara’s top pics
Auto and power remain Elara’s preferred bets, which added that large-cap auto stocks like Maruti Suzuki and Royal Enfield-maker Eicher Motors have corrected sharply since the onset of the US-Iran conflict. While near-term concerns persist around input cost pressures from elevated commodity prices and potential demand moderation in the event of a prolonged conflict triggering an inflation shock for consumers, underlying retail data remains robust and encouraging, it further said.
The domestic brokerage added that Vahan retail registrations so far show strong double-digit growth, and this momentum is expected to receive further tailwinds from the Eighth Pay Commission awards, slated for announcement early next year.Within the power sector, 18 out of the 19 utility stocks under the brokerage’s coverage have outperformed the Nifty 50 in current drawdown, which the firm said underscores the sector’s relative resilience. “The escalating conflict is expected to accelerate India’s electrification cycle, while surging data centre capex is driving incremental power demand. This positive backdrop is further supported by the likely passage of the New Electricity Amendment Bill, which will unlock structural reforms in the sector. Consequently, power generation, transmission, distribution, and data centre-linked plays are emerging not merely as defensive anchors but as clear structural beneficiaries in the medium to long term. NTPC, NLC India, and ACME Solar remain our highest conviction picks within the space,” it added.
Also read: FY26 IPO market a disaster as investors lose money in 2 out of 3 issues. Will next year be better?
Where is the value currently?
In its report, Elara listed out several stocks emerging with better risk-reward dynamics where fundamentals remain intact, and valuation is either trading below the five-year median, and in some cases even below the Russia–Ukraine crisis lows.
These include HDFC Bank, Maruti Suzuki, Eicher Motors, Infosys, LTI Mindtree, L&T, Godrej Properties, NTPC, NLC India, ACME Solar and Eternal.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Business
The Quiet Rituals of Self-Respect: How Everyday Products Shape the Way You Treat Yourself
There’s a subtle difference between self-care and self-respect.
Self-care is often portrayed as something occasional—spa days, special routines, moments carved out for relaxation. It’s visible, sometimes even performative.
Self-respect, on the other hand, is quieter. It lives in the decisions you make when no one is watching. It shows up in consistency, in the standards you set for yourself, and in the way you engage with your daily routines.
And perhaps surprisingly, it’s often reflected in the most ordinary products you use.
The Standard You Accept
Every product you use sets a baseline.
Not just for performance, but for what you consider “good enough.”
If something works “well enough,” you keep using it. If it causes minor irritation or discomfort, you might ignore it. Over time, these small compromises become normalized.
This is how standards quietly drift.
But when you choose something like aluminum and baking soda free deodorant, you’re making a different kind of decision. You’re saying that “good enough” isn’t enough—that your comfort, your skin, and your long-term well-being matter.
It’s not a dramatic statement. It’s a quiet adjustment in standards.
The Daily Mirror
Your routine is a mirror.
Not in the literal sense, but in what it reflects back to you about how you treat yourself.
Do you rush through it, using whatever is easiest?
Do you pay attention to how things feel?
Do you notice when something isn’t working for you?
These questions aren’t about perfection. They’re about awareness.
Using an organic face soap, for example, can shift your experience from purely functional to slightly more intentional. The ingredients, the texture, the way it interacts with your skin—all of it becomes part of a more attentive process.
You’re not just washing your face. You’re engaging with the act.
And that engagement reflects a form of respect.
The Relationship You Have with Routine
Most routines are built on autopilot.
You wake up, go through the motions, and move on. Efficiency takes priority over experience.
But routines are also opportunities.
They’re moments that repeat every day, giving you consistent chances to reinforce how you approach yourself.
When you introduce products that require a bit more attention—like aluminum and baking soda free deodorant—you interrupt the autopilot just enough to notice what you’re doing.
That moment of noticing is small, but it matters.
It turns a routine into a relationship.
Comfort as a Priority, Not a Bonus
In many cases, comfort is treated as optional.
If a product works, slight discomfort is tolerated. It’s seen as a trade-off, not a problem.
But what if comfort were the baseline?
Choosing products that align with your body—ones that avoid common irritants or unnecessary additives—shifts comfort from a bonus to a priority.
An organic face soap, for instance, often emphasizes gentler ingredients. It’s not about doing more—it’s about doing what’s necessary without excess.
This approach respects your skin’s natural state rather than overriding it.
And that respect, repeated daily, becomes part of your standard.
The Language of Consistency
Self-respect is not built on occasional actions. It’s built on consistency.
What you do every day matters more than what you do once in a while.
The products you use daily are part of that consistency. They are tools that either support or undermine your standards.
When you consistently choose items that align with your values—whether that’s comfort, simplicity, or awareness—you reinforce those values internally.
You’re not just making a choice once. You’re making it every day.
Small Decisions, Lasting Impact
It’s easy to dismiss small decisions as insignificant.
A different deodorant.
A different soap.
But these decisions are repeated hundreds, even thousands of times over the course of your life.
And repetition is what gives them weight.
Each time you choose something that aligns with your standards, you reinforce a pattern.
Over time, that pattern becomes part of who you are.
Not in a dramatic way, but in a steady, cumulative one.
Moving Away from Neglect
There’s a subtle form of neglect that often goes unnoticed.
It’s not about ignoring yourself entirely. It’s about settling.
Using products that are “fine.”
Ignoring small discomforts.
Avoiding the effort of finding something better.
This kind of neglect is easy to justify because it doesn’t feel serious.
But over time, it adds up.
Shifting to more intentional choices—like selecting aluminum and baking soda free deodorant or using organic face soap—is a way of moving away from that pattern.
It’s not about perfection. It’s about paying attention.
Respect Without Complexity
There’s a misconception that treating yourself well requires complexity—multiple products, elaborate routines, constant upgrades.
But self-respect doesn’t have to be complicated.
It can be simple.
Choosing products that align with your needs.
Paying attention to how they feel.
Making small adjustments when something isn’t right.
These are straightforward actions, but they carry meaning.
They show that you value your own experience, even in the smallest ways.
The Internal Shift
At first, these choices might feel external—just different products, different routines.
But over time, they create an internal shift.
You become more aware.
More selective.
More aligned with what works for you.
This shift extends beyond personal care.
It influences how you approach other areas of your life:
What you eat.
How you spend your time.
What you prioritize.
It all starts with small, consistent decisions.
Conclusion: The Way You Do Small Things
There’s a well-known idea that the way you do small things reflects the way you do everything.
Your daily routine is made up of small things.
The products you use.
The time you spend.
The attention you give.
By choosing items like aluminum and baking soda free deodorant and organic face soap, you’re not just changing what you use.
You’re changing how you approach yourself.
With more attention.
With higher standards.
With quiet, consistent respect.
And while these changes may seem minor, they have a way of shaping something much larger:
The relationship you have with yourself, every single day.
Business
My Dividend Stock Portfolio: New February Dividend Record – 100 Holdings With 12 Buys
I am working as a Business Analyst and Data Engineer in Germany and have started to build up a portfolio focused on Dividend Growth, both on the high and low-end yield spectrum. Primary focus is on Blue Chips with long-reaching dividend track records. I have been investing for 2 years and have been standing on the sidelines for way too long before. I love developing spreadsheets in Google and Excel to analyze financial performance and integrate these two sources with each other!Happy to connect on the various channels!
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ALL STOCKS MENTIONED either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I am not offering financial advice but only my personal opinion. Investors may take further aspects and their own due diligence into consideration before making a decision.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
Shares climb on glimpse of Iran war exit ramp
The Australian share market has closed higher following reports US President Donald Trump is willing to wind up its military campaign against Iran without first reopening the Strait of Hormuz.
Business
Columbia Small Cap Value And Inflection Fund Q4 2025 Commentary
syahrir maulana/iStock via Getty Images
Our philosophy
Simply put, the upward inflection in stock prices can be a confirmatory signal of fundamental improvement. Our approach to investing is based on our view that fundamentals ultimately drive stock prices. Through deep fundamental research, we
-
NewsBeat6 days agoManchester United reach agreement with Casemiro over contract clause amid transfer speculation
-
News Videos6 days agoParliament publishes latest register of MPs’ financial interests
-
NewsBeat4 days agoThe Story hosts event on Durham’s historic registers
-
Tech5 days agoIntercom’s new post-trained Fin Apex 1.0 beats GPT-5.4 and Claude Sonnet 4.6 at customer service resolutions
-
Business5 days agoInstagram, YouTube Found Responsible for Teen’s Mental Health Struggle in Historic Ruling
-
NewsBeat6 days agoTesco is selling new Cadbury Dairy Milk bar and people can’t wait to try it
-
Sports4 days agoSweet Sixteen Game Thread: Tide vs Michigan
-
NewsBeat7 days agoEntrepreneurs Forum survey reveals optimism in North East
-
Entertainment3 days agoLana Del Rey Celebrates Her Husband’s 51st Birthday In New Post
-
Entertainment1 day ago
Fans slam 'heartbreaking' Barbie Dream Fest convention debacle with 'cardboard cutout' experience
-
Sports6 days agoFantasy Baseball Week 1 Preview: Top sleeper hitters for both five- and 12-day period led by Munetaka Murakami
-
Tech6 days agoUS FCC Prohibits Approval Of New Foreign-Made Consumer Routers
-
Tech7 days agoEmbedding compliance in AI adoption
-
Fashion7 days agoCoffee Break: Korean Skincare Set
-
Sports6 days ago
One Team in Particular Is Monitoring Kirk Cousins
-
Crypto World5 hours ago
Dems press CFTC, ethics board on prediction-market insider trades
-
Fashion7 days agoAlthea Mink: Patrice Taylor’s Atlanta Couture Brand Built on Legacy, Resilience, and Architectural Glamour
-
NewsBeat7 days agoDWP to close two benefits for all new and existing claimants before April
-
Fashion6 days agoHow to Style Spring Like WeWoreWhat: Easy Outfit Ideas for 2026
-
Sports7 days agoBhubaneswar gets 2028 World Indoor Athletics Championships hosting rights | Other Sports News

You must be logged in to post a comment Login